Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor

Dopamine receptor agonists are used for the treatment of various psychiatric diseases. Here, the authors screen approximately three million compounds and identify a novel class of D1R agonists that do not have a catechol scaffold and possess promising pharmacokinetic properties.

書目詳細資料

Principais autores:	David L. Gray, John A. Allen, Scot Mente, Rebecca E. O’Connor, George J. DeMarco, Ivan Efremov, Patrick Tierney, Dmitri Volfson, Jennifer Davoren, Edward Guilmette, Michelle Salafia, Rouba Kozak, Michael D. Ehlers
格式:	Artigo
語言:	Inglês
出版:	Nature Portfolio 2018-02-01
叢編:	Nature Communications
在線閱讀:	https://doi.org/10.1038/s41467-017-02776-7
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!